Birmingham Research Study
New Research for
Moderate-to-Severe
Eczema
Doctors in Birmingham are evaluating an investigational medication for adults with moderate-to-severe atopic dermatitis.
Location
Birmingham, AL
Study Duration
25 Weeks
Treatment Visits
12 visits over a span of 25 weeks
Expert Care
No Cost
About the Study
Investigating potential new relief options.
Evaluating an investigational medication for adults with moderate-to-severe atopic dermatitis (eczema).
Researchers are exploring a new potential option to see if it can help relieve pain, itch, and skin irritation in adults who have not seen adequate results from topical treatments.
What to Expect
Your participation journey
Phase 1
Screening and baseline baseline assessments to ensure the study is a match.
Investigational Care
Medication administered via subcutaneous injection with expert monitoring.
Dermatologic Monitoring
Periodic outpatient visits for blood draws, ECGs, and skin assessments.
Who Can Participate?
- Adults ages 18-65
- Eczema diagnosis for ≥6 months
- Moderate-to-severe symptoms
- Inadequate response to topicals
.png)
.png)
Compensation
Support for your involvement
Participants will receive all study-related care and study medication at no cost.
Participants will be compensated for their time and travel to attend required study visits. All information collected is kept strictly confidential.
Advance research for potential eczema relief
Click below and complete our short screener to see if you qualify to join us in Birmingham.
See If You QualifyFrequently Asked Questions
Researchers are evaluating an investigational medication to see if it can address the underlying source of inflammation in eczema.
This is an early-phase study designed to evaluate the safety and processing of the investigational medication in the body.
Certain topical and systemic treatments require a "washout" period before joining. Our team will review your current medications with you during the screening process.
